The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFX.L Regulatory News (AFX)

  • There is currently no data for AFX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revision to APS Employee Share Ownership Scheme

23 Dec 2021 07:00

RNS Number : 5459W
Alpha FX Group PLC
23 December 2021
 

23 December 2021

 

Alpha FX Group plc

("Alpha FX" or the "Group")

Revision to Alpha Payments Solutions Employee Share Ownership Scheme

 

Following the continued success of the Alpha Platform Solutions Division ("APS"), the Group has adjusted the APS employee share ownership scheme to include additional new employees. In order to enable equity to be awarded to the new employees to support the ongoing growth of the division, Adam Dowling, Managing Director of APS, has agreed to reduce his shareholding in Alpha FX Limited from 10% to 7.5%, and the Group has agreed to reduce its shareholding in Alpha FX Limited from 82% to 81.6%. As a result, a new class of non-dividend bearing and non-voting D3 shares ("D3 Shares") has been issued to 3 employees ("D3 Shareholders") and another new class of non-dividend bearing and non-voting D4 shares ("D4 Shares") has been issued to 15 employees ("D4 Shareholders"). The value of the D3 Shares and D4 Shares will be linked to the performance of the APS business and are structured in a similar way to the existing D shares issued in 2019. 

The D3 Shareholders will have the option to convert 25% of their holding of D3 Shares into ordinary shares of £0.002 in the Group ("Group Shares") each year for four years commencing from March 2024 (with the final option being exercisable in March 2027). The D4 Shareholders will have the option to convert 25% of their holding of D4 Shares into Group Shares each year for four years commencing from March 2025 (with the final option being exercisable in March 2028). At conversion, and in exchange for converting their D3 shares and D4 Shares into Group Shares, the D3 shares held by the D3 Shareholders and the D4 Shares held by the D4 Shareholders in Alpha FX Limited will commensurately decrease and the Group's holding will commensurately increase.

 

Enquiries:

Alpha FX Group plc via Alma PR

Morgan Tillbrook, Founder and CEO

Tim Kidd, CFO

 

Liberum Capital Limited (Nominated Adviser and Sole Broker) Tel: +44 (0) 20 3100 2000

Neil Patel

Cameron Duncan

Kane Collings

 

Alma PR (Financial Public Relations) Tel: +44 0203 405 0205

Josh Royston

Andy Bryant

Kieran Breheny

 

Notes to Editors

Alpha provides FX risk management and alternative banking solutions to corporates and institutions across the UK, Europe and Canada. Combining leading expertise and technology, the Group partners with a small number of high value clients, to provide enterprise-level solutions across four key areas: FX risk management, international payments, accounts and collections.

 

Since it was incorporated in 2010, Alpha FX has been able to build and retain a high-quality client base that includes a number of highly respected brands.

 

Market Abuse Regulation

This announcement is released by Alpha FX Group plc and contains inside information for the purposes of the Market Abuse Regulation (EU) 596/2014 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person who arranged for the release of this announcement on behalf of Alpha FX Group plc was Tim Kidd, Chief Financial Officer.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDLLFLFLLBFBL
Date   Source Headline
14th Dec 20215:59 pmRNSHolding(s) in Company
8th Dec 20217:00 amRNSTrading Update
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSBoard Appointment
4th Oct 20214:19 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSLaunch of next-generation banking platform
9th Sep 20212:44 pmRNSIssue of Equity
1st Sep 20217:00 amRNSInterim Report
13th Aug 202110:57 amRNSHolding(s) in Company
16th Jul 202110:29 amRNSHolding(s) in Company
14th Jul 20217:00 amRNSTrading Update
28th May 20217:00 amRNSNetherlands Office Share Ownership Scheme
27th May 20211:50 pmRNSDirector/PDMR Dealing
27th May 20217:00 amRNSTrading Update
19th May 20217:00 amRNSBoard Appointment
5th May 202110:53 amRNSResult of AGM
15th Apr 20217:00 amRNSExercise of Options
13th Apr 20217:00 amRNSDirector/PDMR Shareholding
9th Apr 20217:00 amRNSNotice of AGM & Posting of Annual Report
23rd Mar 20214:16 pmRNSDirector/PDMR Dealings
17th Mar 20217:00 amRNSFull Year Results
22nd Feb 20215:56 pmRNSHolding(s) in Company
18th Feb 20212:56 pmRNSReplacement - Holding(s) in Company
12th Jan 20217:00 amRNSTrading Update
3rd Dec 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSDirectorate Change
1st Oct 20207:00 amRNSTrading Update
30th Sep 20204:31 pmRNSHolding(s) in Company
16th Sep 20209:44 amRNSHolding(s) in Company
16th Sep 20209:42 amRNSHolding(s) in Company
11th Sep 20203:42 pmRNSHolding(s) in Company
11th Sep 202010:59 amRNSOption Exercise and Total Voting Rights
10th Sep 20201:30 pmRNSResult of secondary placing of Ordinary Shares
10th Sep 20207:00 amRNSProposed secondary placing of Ordinary Shares
2nd Sep 20207:00 amRNSInterim Report
13th Aug 20207:00 amRNSExercise of Options
15th Jul 20204:40 pmRNSSecond Price Monitoring Extn
15th Jul 20204:35 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSTrading Update
6th Jul 20205:12 pmRNSReplacement: Holding(s) in Company
6th Jul 20209:22 amRNSHolding(s) in Company
6th Jul 20209:20 amRNSHolding(s) in Company
24th Jun 202010:36 amRNSResult of AGM
19th Jun 20201:40 pmRNSDirector/PDMR Shareholding
2nd Jun 20203:59 pmRNSHolding(s) in Company
1st Jun 20202:07 pmRNSNotice of Annual General Meeting
19th May 20207:00 amRNSJames Carey Appointed Director of Technology
11th May 20207:00 amRNSUpdate on Employee Share Schemes and Board Update
20th Apr 20207:00 amRNSDirectorate Change
9th Apr 20205:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.